UC activity after OLT | |||
---|---|---|---|
Patient characteristics | Same–Quiescent | Worse–Active | p Value |
Sex (M/F) | 4/4 | 7/1 | 0.28 |
Age (years) at OLT | 42 (12) | 30 (11) | 0.11 |
Age (years) at UC diagnosis | 31 (12) | 22 (6) | 0.11 |
Median (range) duration of UC (months) | 86 (3-480) | 85 (2-250) | 0.64 |
Median (range) duration of PSC (months) | 47 (12-360) | 60 (3-164) | 0.94 |
Pretransplant UC course (n) | 0.08 | ||
Quiescent | 8 | 4 | |
Active | 0 | 4 | |
Immunosuppression (n) | 0.64 | ||
Cyclosporin | 3 | 2 | |
Cyclosporin3-150+azathioprine | 5 | 63-150 |
↵3-150 One patient was on tacrolimus.